0
USD
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Polio Vaccine Market Research Report 2021
Published Date: February 2021
|
Report Code: QYRE-Auto-18B4237
Home | Category |Health |Health Conditions |Infectious Diseases
Global Polio Vaccine Market Research Report 2021

Global Polio Vaccine Market Research Report 2021

Code: QYRE-Auto-18B4237
Report
February 2021
99 Pages
QYResearch
Region: Global, North America, Germany, Europe, Canada, France, Brazil, Middle East & Africa, Turkey, Saudi Arabia, Argentina, Vietnam, India, Australia, Thailand, Malaysia, Taiwan, Philippines, Italy, Japan, South Korea, Indonesia,
Description
Table of Content
Tables & Figures
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
    Inactivated Polio Vaccine (IPV)
    Oral Polio Vaccine (OPV)
Segment by Application
    Public
    Private
By Region
    North America
        U.S.
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Asia-Pacific
        China
        Japan
        South Korea
        India
        Australia
        Taiwan
        Indonesia
        Thailand
        Malaysia
        Philippines
        Vietnam
    Latin America
        Mexico
        Brazil
        Argentina
    Middle East & Africa
        Turkey
        Saudi Arabia
        U.A.E
By Company
    Sanofi
    GSK
    Bibcol
    Serum Institute
    Tiantan Biological
    IMBCA
    Panacea Biotec Ltd
    Bio-Med
    Halfkin Bio-Pharmaceuticals
1 Polio Vaccine Market Overview
1.1 Product Overview and Scope of Polio Vaccine
1.2 Polio Vaccine Segment by Type
1.2.1 Global Polio Vaccine Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Inactivated Polio Vaccine (IPV)
1.2.3 Oral Polio Vaccine (OPV)
1.3 Polio Vaccine Segment by Application
1.3.1 Polio Vaccine Sales Comparison by Application: (2021-2027)
1.3.2 Public
1.3.3 Private
1.4 Global Polio Vaccine Market Size Estimates and Forecasts
1.4.1 Global Polio Vaccine Revenue 2016-2027
1.4.2 Global Polio Vaccine Sales 2016-2027
1.4.3 Polio Vaccine Market Size by Region: 2016 Versus 2021 Versus 2027
2 Polio Vaccine Market Competition by Manufacturers
2.1 Global Polio Vaccine Sales Market Share by Manufacturers (2016-2021)
2.2 Global Polio Vaccine Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Polio Vaccine Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Polio Vaccine Manufacturing Sites, Area Served, Product Type
2.5 Polio Vaccine Market Competitive Situation and Trends
2.5.1 Polio Vaccine Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Polio Vaccine Players Market Share by Revenue
2.5.3 Global Polio Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Polio Vaccine Retrospective Market Scenario by Region
3.1 Global Polio Vaccine Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Polio Vaccine Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Polio Vaccine Market Facts & Figures by Country
3.3.1 North America Polio Vaccine Sales by Country
3.3.2 North America Polio Vaccine Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Polio Vaccine Market Facts & Figures by Country
3.4.1 Europe Polio Vaccine Sales by Country
3.4.2 Europe Polio Vaccine Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Polio Vaccine Market Facts & Figures by Region
3.5.1 Asia Pacific Polio Vaccine Sales by Region
3.5.2 Asia Pacific Polio Vaccine Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Polio Vaccine Market Facts & Figures by Country
3.6.1 Latin America Polio Vaccine Sales by Country
3.6.2 Latin America Polio Vaccine Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Polio Vaccine Market Facts & Figures by Country
3.7.1 Middle East and Africa Polio Vaccine Sales by Country
3.7.2 Middle East and Africa Polio Vaccine Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Polio Vaccine Historic Market Analysis by Type
4.1 Global Polio Vaccine Sales Market Share by Type (2016-2021)
4.2 Global Polio Vaccine Revenue Market Share by Type (2016-2021)
4.3 Global Polio Vaccine Price by Type (2016-2021)
5 Global Polio Vaccine Historic Market Analysis by Application
5.1 Global Polio Vaccine Sales Market Share by Application (2016-2021)
5.2 Global Polio Vaccine Revenue Market Share by Application (2016-2021)
5.3 Global Polio Vaccine Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Sanofi
6.1.1 Sanofi Corporation Information
6.1.2 Sanofi Description and Business Overview
6.1.3 Sanofi Polio Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Sanofi Product Portfolio
6.1.5 Sanofi Recent Developments/Updates
6.2 GSK
6.2.1 GSK Corporation Information
6.2.2 GSK Description and Business Overview
6.2.3 GSK Polio Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.2.4 GSK Product Portfolio
6.2.5 GSK Recent Developments/Updates
6.3 Bibcol
6.3.1 Bibcol Corporation Information
6.3.2 Bibcol Description and Business Overview
6.3.3 Bibcol Polio Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Bibcol Product Portfolio
6.3.5 Bibcol Recent Developments/Updates
6.4 Serum Institute
6.4.1 Serum Institute Corporation Information
6.4.2 Serum Institute Description and Business Overview
6.4.3 Serum Institute Polio Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Serum Institute Product Portfolio
6.4.5 Serum Institute Recent Developments/Updates
6.5 Tiantan Biological
6.5.1 Tiantan Biological Corporation Information
6.5.2 Tiantan Biological Description and Business Overview
6.5.3 Tiantan Biological Polio Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Tiantan Biological Product Portfolio
6.5.5 Tiantan Biological Recent Developments/Updates
6.6 IMBCA
6.6.1 IMBCA Corporation Information
6.6.2 IMBCA Description and Business Overview
6.6.3 IMBCA Polio Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.6.4 IMBCA Product Portfolio
6.6.5 IMBCA Recent Developments/Updates
6.7 Panacea Biotec Ltd
6.6.1 Panacea Biotec Ltd Corporation Information
6.6.2 Panacea Biotec Ltd Description and Business Overview
6.6.3 Panacea Biotec Ltd Polio Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Panacea Biotec Ltd Product Portfolio
6.7.5 Panacea Biotec Ltd Recent Developments/Updates
6.8 Bio-Med
6.8.1 Bio-Med Corporation Information
6.8.2 Bio-Med Description and Business Overview
6.8.3 Bio-Med Polio Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Bio-Med Product Portfolio
6.8.5 Bio-Med Recent Developments/Updates
6.9 Halfkin Bio-Pharmaceuticals
6.9.1 Halfkin Bio-Pharmaceuticals Corporation Information
6.9.2 Halfkin Bio-Pharmaceuticals Description and Business Overview
6.9.3 Halfkin Bio-Pharmaceuticals Polio Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Halfkin Bio-Pharmaceuticals Product Portfolio
6.9.5 Halfkin Bio-Pharmaceuticals Recent Developments/Updates
7 Polio Vaccine Manufacturing Cost Analysis
7.1 Polio Vaccine Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Polio Vaccine
7.4 Polio Vaccine Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Polio Vaccine Distributors List
8.3 Polio Vaccine Customers
9 Polio Vaccine Market Dynamics
9.1 Polio Vaccine Industry Trends
9.2 Polio Vaccine Growth Drivers
9.3 Polio Vaccine Market Challenges
9.4 Polio Vaccine Market Restraints
10 Global Market Forecast
10.1 Polio Vaccine Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Polio Vaccine by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Polio Vaccine by Type (2022-2027)
10.2 Polio Vaccine Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Polio Vaccine by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Polio Vaccine by Application (2022-2027)
10.3 Polio Vaccine Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Polio Vaccine by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Polio Vaccine by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
    Table 1. Global Polio Vaccine Sales (M Doses) Growth Rate Comparison by Type (2021-2027)
    Table 2. Global Polio Vaccine Sales (M Doses) Comparison by Application (2021-2027)
    Table 3. Global Polio Vaccine Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
    Table 4. Key Manufacturers Polio Vaccine Covered in This Study
    Table 5. Global Polio Vaccine Sales (M Doses) of Key Manufacturers (2016-2021)
    Table 6. Global Polio Vaccine Sales Share by Manufacturers (2016-2021)
    Table 7. Global Polio Vaccine Revenue (US$ Million) by Manufacturers (2016-2021)
    Table 8. Global Polio Vaccine Revenue Share by Manufacturers (2016-2021)
    Table 9. Global Market Polio Vaccine Average Price (USD/K Doses) of Key Manufacturers (2016-2021)
    Table 10. Manufacturers Polio Vaccine Manufacturing Sites and Area Served
    Table 11. Manufacturers Polio Vaccine Product Type
    Table 12. Global Polio Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 13. Global Polio Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Polio Vaccine as of 2020)
    Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 15. Global Polio Vaccine Sales by Region (2016-2021) & (M Doses)
    Table 16. Global Polio Vaccine Sales Market Share by Region (2016-2021)
    Table 17. Global Polio Vaccine Revenue by Region (2016-2021) & (US$ Million)
    Table 18. North America Polio Vaccine Sales by Country (2016-2021) & (M Doses)
    Table 19. North America Polio Vaccine Sales Market Share by Country (2016-2021)
    Table 20. North America Polio Vaccine Revenue by Country (2016-2021) & (US$ Million)
    Table 21. North America Polio Vaccine Revenue Market Share by Country (2016-2021)
    Table 22. Europe Polio Vaccine Sales by Country (2016-2021) & (M Doses)
    Table 23. Europe Polio Vaccine Sales Market Share by Country (2016-2021)
    Table 24. Europe Polio Vaccine Revenue by Country (2016-2021) & (US$ Million)
    Table 25. Europe Polio Vaccine Revenue Market Share by Country (2016-2021)
    Table 26. Asia Pacific Polio Vaccine Sales by Region (2016-2021) & (M Doses)
    Table 27. Asia Pacific Polio Vaccine Sales Market Share by Region (2016-2021)
    Table 28. Asia Pacific Polio Vaccine Revenue by Region (2016-2021) & (US$ Million)
    Table 29. Asia Pacific Polio Vaccine Revenue Market Share by Region (2016-2021)
    Table 30. Latin America Polio Vaccine Sales by Country (2016-2021) & (M Doses)
    Table 31. Latin America Polio Vaccine Sales Market Share by Country (2016-2021)
    Table 32. Latin America Polio Vaccine Revenue by Country (2016-2021) & (US$ Million)
    Table 33. Latin America Polio Vaccine Revenue Market Share by Country (2016-2021)
    Table 34. Middle East and Africa Polio Vaccine Sales by Country (2016-2021) & (M Doses)
    Table 35. Middle East and Africa Polio Vaccine Sales Market Share by Country (2016-2021)
    Table 36. Middle East and Africa Polio Vaccine Revenue by Country (2016-2021) & (US$ Million)
    Table 37. Middle East and Africa Polio Vaccine Revenue Market Share by Country (2016-2021)
    Table 38. Global Polio Vaccine Sales (M Doses) by Type (2016-2021)
    Table 39. Global Polio Vaccine Sales Market Share by Type (2016-2021)
    Table 40. Global Polio Vaccine Revenue (Million US$) by Type (2016-2021)
    Table 41. Global Polio Vaccine Revenue Share by Type (2016-2021)
    Table 42. Global Polio Vaccine Price (USD/K Doses) by Type (2016-2021)
    Table 43. Global Polio Vaccine Sales (M Doses) by Application (2016-2021)
    Table 44. Global Polio Vaccine Sales Market Share by Application (2016-2021)
    Table 45. Global Polio Vaccine Revenue (Million US$) by Application (2016-2021)
    Table 46. Global Polio Vaccine Revenue Share by Application (2016-2021)
    Table 47. Global Polio Vaccine Price (USD/K Doses) by Application (2016-2021)
    Table 48. Sanofi Corporation Information
    Table 49. Sanofi Description and Business Overview
    Table 50. Sanofi Polio Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2016-2021)
    Table 51. Sanofi Polio Vaccine Product
    Table 52. Sanofi Recent Developments/Updates
    Table 53. GSK Corporation Information
    Table 54. GSK Description and Business Overview
    Table 55. GSK Polio Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2016-2021)
    Table 56. GSK Polio Vaccine Product
    Table 57. GSK Recent Developments/Updates
    Table 58. Bibcol Corporation Information
    Table 59. Bibcol Description and Business Overview
    Table 60. Bibcol Polio Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2016-2021)
    Table 61. Bibcol Polio Vaccine Product
    Table 62. Bibcol Recent Developments/Updates
    Table 63. Serum Institute Corporation Information
    Table 64. Serum Institute Description and Business Overview
    Table 65. Serum Institute Polio Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2016-2021)
    Table 66. Serum Institute Polio Vaccine Product
    Table 67. Serum Institute Recent Developments/Updates
    Table 68. Tiantan Biological Corporation Information
    Table 69. Tiantan Biological Description and Business Overview
    Table 70. Tiantan Biological Polio Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2016-2021)
    Table 71. Tiantan Biological Polio Vaccine Product
    Table 72. Tiantan Biological Recent Developments/Updates
    Table 73. IMBCA Corporation Information
    Table 74. IMBCA Description and Business Overview
    Table 75. IMBCA Polio Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2016-2021)
    Table 76. IMBCA Polio Vaccine Product
    Table 77. IMBCA Recent Developments/Updates
    Table 78. Panacea Biotec Ltd Corporation Information
    Table 79. Panacea Biotec Ltd Description and Business Overview
    Table 80. Panacea Biotec Ltd Polio Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2016-2021)
    Table 81. Panacea Biotec Ltd Polio Vaccine Product
    Table 82. Panacea Biotec Ltd Recent Developments/Updates
    Table 83. Bio-Med Corporation Information
    Table 84. Bio-Med Description and Business Overview
    Table 85. Bio-Med Polio Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2016-2021)
    Table 86. Bio-Med Polio Vaccine Product
    Table 87. Bio-Med Recent Developments/Updates
    Table 88. Halfkin Bio-Pharmaceuticals Corporation Information
    Table 89. Halfkin Bio-Pharmaceuticals Description and Business Overview
    Table 90. Halfkin Bio-Pharmaceuticals Polio Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2016-2021)
    Table 91. Halfkin Bio-Pharmaceuticals Polio Vaccine Product
    Table 92. Halfkin Bio-Pharmaceuticals Recent Developments/Updates
    Table 93. Production Base and Market Concentration Rate of Raw Material
    Table 94. Key Suppliers of Raw Materials
    Table 95. Polio Vaccine Distributors List
    Table 96. Polio Vaccine Customers List
    Table 97. Polio Vaccine Market Trends
    Table 98. Polio Vaccine Growth Drivers
    Table 99. Polio Vaccine Market Restraints
    Table 100. Global Polio Vaccine Sales Forecast by Type (2022-2027) & (M Doses)
    Table 101. Global Polio Vaccine Sales Market Share Forecast by Type (2022-2027)
    Table 102. Global Polio Vaccine Revenue Forecast by Type (2022-2027) & (US$ Million)
    Table 103. Global Polio Vaccine Revenue Market Share Forecast by Type (2022-2027)
    Table 104. Global Polio Vaccine Sales Forecast by Application (2022-2027) & (M Doses)
    Table 105. Global Polio Vaccine Sales Market Share Forecast by Application (2022-2027)
    Table 106. Global Polio Vaccine Revenue Forecast by Application (2022-2027) & (US$ Million)
    Table 107. Global Polio Vaccine Revenue Market Share Forecast by Application (2022-2027)
    Table 108. Global Polio Vaccine Sales Forecast by Region (2022-2027) & (M Doses)
    Table 109. Global Polio Vaccine Sales Market Share Forecast by Region (2022-2027)
    Table 110. Global Polio Vaccine Revenue Forecast by Region (2022-2027) & (US$ Million)
    Table 111. Global Polio Vaccine Revenue Market Share Forecast by Region (2022-2027)
    Table 112. Research Programs/Design for This Report
    Table 113. Key Data Information from Secondary Sources
    Table 114. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Polio Vaccine
    Figure 2. Global Polio Vaccine Market Share by Type in 2020 & 2027
    Figure 3. Inactivated Polio Vaccine (IPV) Product Picture
    Figure 4. Oral Polio Vaccine (OPV) Product Picture
    Figure 5. Global Polio Vaccine Market Share by Application in 2020 & 2027
    Figure 6. Public
    Figure 7. Private
    Figure 8. Global Polio Vaccine Revenue, (US$ Million), 2016 VS 2021 VS 2027
    Figure 9. Global Polio Vaccine Market Size 2016-2027 (US$ Million)
    Figure 10. Global Polio Vaccine Sales 2016-2027 (M Doses)
    Figure 11. Global Polio Vaccine Market Size Market Share by Region: 2016 VS 20210 VS 2027
    Figure 12. Polio Vaccine Sales Share by Manufacturers in 2020
    Figure 13. Global Polio Vaccine Revenue Share by Manufacturers in 2020
    Figure 14. The Global 5 and 10 Largest Polio Vaccine Players: Market Share by Revenue in 2020
    Figure 15. Polio Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
    Figure 16. Global Polio Vaccine Sales Market Share by Region (2016-2021)
    Figure 17. Global Polio Vaccine Sales Market Share by Region in 2020
    Figure 18. Global Polio Vaccine Revenue Market Share by Region (2016-2021)
    Figure 19. Global Polio Vaccine Revenue Market Share by Region in 2020
    Figure 20. U.S. Polio Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 21. Canada Polio Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 22. Germany Polio Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 23. France Polio Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 24. U.K. Polio Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 25. Italy Polio Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 26. Russia Polio Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 27. China Polio Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 28. Japan Polio Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 29. South Korea Polio Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 30. India Polio Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 31. Australia Polio Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 32. Taiwan Polio Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 33. Indonesia Polio Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 34. Thailand Polio Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 35. Malaysia Polio Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 36. Philippines Polio Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 37. Vietnam Polio Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 38. Mexico Polio Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 39. Brazil Polio Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 40. Argentina Polio Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 41. Turkey Polio Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 42. Saudi Arabia Polio Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 43. U.A.E Polio Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 44. Sales Market Share of Polio Vaccine by Type (2016-2021)
    Figure 45. Sales Market Share of Polio Vaccine by Application (2016-2021)
    Figure 46. Sales Market Share of Polio Vaccine by Application in 2020
    Figure 47. Revenue Share of Polio Vaccine by Application (2016-2021)
    Figure 48. Revenue Share of Polio Vaccine by Application in 2020
    Figure 49. Manufacturing Cost Structure of Polio Vaccine
    Figure 50. Manufacturing Process Analysis of Polio Vaccine
    Figure 51. Polio Vaccine Industrial Chain Analysis
    Figure 52. Channels of Distribution
    Figure 53. Distributors Profiles
    Figure 54. Bottom-up and Top-down Approaches for This Report
    Figure 55. Data Triangulation
    Figure 56. Key Executives Interviewed
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
    Inactivated Polio Vaccine (IPV)
    Oral Polio Vaccine (OPV)
Segment by Application
    Public
    Private
By Region
    North America
        U.S.
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Asia-Pacific
        China
        Japan
        South Korea
        India
        Australia
        Taiwan
        Indonesia
        Thailand
        Malaysia
        Philippines
        Vietnam
    Latin America
        Mexico
        Brazil
        Argentina
    Middle East & Africa
        Turkey
        Saudi Arabia
        U.A.E
By Company
    Sanofi
    GSK
    Bibcol
    Serum Institute
    Tiantan Biological
    IMBCA
    Panacea Biotec Ltd
    Bio-Med
    Halfkin Bio-Pharmaceuticals
Read More
1 Polio Vaccine Market Overview
1.1 Product Overview and Scope of Polio Vaccine
1.2 Polio Vaccine Segment by Type
1.2.1 Global Polio Vaccine Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Inactivated Polio Vaccine (IPV)
1.2.3 Oral Polio Vaccine (OPV)
1.3 Polio Vaccine Segment by Application
1.3.1 Polio Vaccine Sales Comparison by Application: (2021-2027)
1.3.2 Public
1.3.3 Private
1.4 Global Polio Vaccine Market Size Estimates and Forecasts
1.4.1 Global Polio Vaccine Revenue 2016-2027
1.4.2 Global Polio Vaccine Sales 2016-2027
1.4.3 Polio Vaccine Market Size by Region: 2016 Versus 2021 Versus 2027
2 Polio Vaccine Market Competition by Manufacturers
2.1 Global Polio Vaccine Sales Market Share by Manufacturers (2016-2021)
2.2 Global Polio Vaccine Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Polio Vaccine Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Polio Vaccine Manufacturing Sites, Area Served, Product Type
2.5 Polio Vaccine Market Competitive Situation and Trends
2.5.1 Polio Vaccine Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Polio Vaccine Players Market Share by Revenue
2.5.3 Global Polio Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Polio Vaccine Retrospective Market Scenario by Region
3.1 Global Polio Vaccine Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Polio Vaccine Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Polio Vaccine Market Facts & Figures by Country
3.3.1 North America Polio Vaccine Sales by Country
3.3.2 North America Polio Vaccine Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Polio Vaccine Market Facts & Figures by Country
3.4.1 Europe Polio Vaccine Sales by Country
3.4.2 Europe Polio Vaccine Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Polio Vaccine Market Facts & Figures by Region
3.5.1 Asia Pacific Polio Vaccine Sales by Region
3.5.2 Asia Pacific Polio Vaccine Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Polio Vaccine Market Facts & Figures by Country
3.6.1 Latin America Polio Vaccine Sales by Country
3.6.2 Latin America Polio Vaccine Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Polio Vaccine Market Facts & Figures by Country
3.7.1 Middle East and Africa Polio Vaccine Sales by Country
3.7.2 Middle East and Africa Polio Vaccine Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Polio Vaccine Historic Market Analysis by Type
4.1 Global Polio Vaccine Sales Market Share by Type (2016-2021)
4.2 Global Polio Vaccine Revenue Market Share by Type (2016-2021)
4.3 Global Polio Vaccine Price by Type (2016-2021)
5 Global Polio Vaccine Historic Market Analysis by Application
5.1 Global Polio Vaccine Sales Market Share by Application (2016-2021)
5.2 Global Polio Vaccine Revenue Market Share by Application (2016-2021)
5.3 Global Polio Vaccine Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Sanofi
6.1.1 Sanofi Corporation Information
6.1.2 Sanofi Description and Business Overview
6.1.3 Sanofi Polio Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Sanofi Product Portfolio
6.1.5 Sanofi Recent Developments/Updates
6.2 GSK
6.2.1 GSK Corporation Information
6.2.2 GSK Description and Business Overview
6.2.3 GSK Polio Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.2.4 GSK Product Portfolio
6.2.5 GSK Recent Developments/Updates
6.3 Bibcol
6.3.1 Bibcol Corporation Information
6.3.2 Bibcol Description and Business Overview
6.3.3 Bibcol Polio Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Bibcol Product Portfolio
6.3.5 Bibcol Recent Developments/Updates
6.4 Serum Institute
6.4.1 Serum Institute Corporation Information
6.4.2 Serum Institute Description and Business Overview
6.4.3 Serum Institute Polio Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Serum Institute Product Portfolio
6.4.5 Serum Institute Recent Developments/Updates
6.5 Tiantan Biological
6.5.1 Tiantan Biological Corporation Information
6.5.2 Tiantan Biological Description and Business Overview
6.5.3 Tiantan Biological Polio Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Tiantan Biological Product Portfolio
6.5.5 Tiantan Biological Recent Developments/Updates
6.6 IMBCA
6.6.1 IMBCA Corporation Information
6.6.2 IMBCA Description and Business Overview
6.6.3 IMBCA Polio Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.6.4 IMBCA Product Portfolio
6.6.5 IMBCA Recent Developments/Updates
6.7 Panacea Biotec Ltd
6.6.1 Panacea Biotec Ltd Corporation Information
6.6.2 Panacea Biotec Ltd Description and Business Overview
6.6.3 Panacea Biotec Ltd Polio Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Panacea Biotec Ltd Product Portfolio
6.7.5 Panacea Biotec Ltd Recent Developments/Updates
6.8 Bio-Med
6.8.1 Bio-Med Corporation Information
6.8.2 Bio-Med Description and Business Overview
6.8.3 Bio-Med Polio Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Bio-Med Product Portfolio
6.8.5 Bio-Med Recent Developments/Updates
6.9 Halfkin Bio-Pharmaceuticals
6.9.1 Halfkin Bio-Pharmaceuticals Corporation Information
6.9.2 Halfkin Bio-Pharmaceuticals Description and Business Overview
6.9.3 Halfkin Bio-Pharmaceuticals Polio Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Halfkin Bio-Pharmaceuticals Product Portfolio
6.9.5 Halfkin Bio-Pharmaceuticals Recent Developments/Updates
7 Polio Vaccine Manufacturing Cost Analysis
7.1 Polio Vaccine Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Polio Vaccine
7.4 Polio Vaccine Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Polio Vaccine Distributors List
8.3 Polio Vaccine Customers
9 Polio Vaccine Market Dynamics
9.1 Polio Vaccine Industry Trends
9.2 Polio Vaccine Growth Drivers
9.3 Polio Vaccine Market Challenges
9.4 Polio Vaccine Market Restraints
10 Global Market Forecast
10.1 Polio Vaccine Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Polio Vaccine by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Polio Vaccine by Type (2022-2027)
10.2 Polio Vaccine Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Polio Vaccine by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Polio Vaccine by Application (2022-2027)
10.3 Polio Vaccine Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Polio Vaccine by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Polio Vaccine by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
Read More
List of Tables
    Table 1. Global Polio Vaccine Sales (M Doses) Growth Rate Comparison by Type (2021-2027)
    Table 2. Global Polio Vaccine Sales (M Doses) Comparison by Application (2021-2027)
    Table 3. Global Polio Vaccine Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
    Table 4. Key Manufacturers Polio Vaccine Covered in This Study
    Table 5. Global Polio Vaccine Sales (M Doses) of Key Manufacturers (2016-2021)
    Table 6. Global Polio Vaccine Sales Share by Manufacturers (2016-2021)
    Table 7. Global Polio Vaccine Revenue (US$ Million) by Manufacturers (2016-2021)
    Table 8. Global Polio Vaccine Revenue Share by Manufacturers (2016-2021)
    Table 9. Global Market Polio Vaccine Average Price (USD/K Doses) of Key Manufacturers (2016-2021)
    Table 10. Manufacturers Polio Vaccine Manufacturing Sites and Area Served
    Table 11. Manufacturers Polio Vaccine Product Type
    Table 12. Global Polio Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 13. Global Polio Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Polio Vaccine as of 2020)
    Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 15. Global Polio Vaccine Sales by Region (2016-2021) & (M Doses)
    Table 16. Global Polio Vaccine Sales Market Share by Region (2016-2021)
    Table 17. Global Polio Vaccine Revenue by Region (2016-2021) & (US$ Million)
    Table 18. North America Polio Vaccine Sales by Country (2016-2021) & (M Doses)
    Table 19. North America Polio Vaccine Sales Market Share by Country (2016-2021)
    Table 20. North America Polio Vaccine Revenue by Country (2016-2021) & (US$ Million)
    Table 21. North America Polio Vaccine Revenue Market Share by Country (2016-2021)
    Table 22. Europe Polio Vaccine Sales by Country (2016-2021) & (M Doses)
    Table 23. Europe Polio Vaccine Sales Market Share by Country (2016-2021)
    Table 24. Europe Polio Vaccine Revenue by Country (2016-2021) & (US$ Million)
    Table 25. Europe Polio Vaccine Revenue Market Share by Country (2016-2021)
    Table 26. Asia Pacific Polio Vaccine Sales by Region (2016-2021) & (M Doses)
    Table 27. Asia Pacific Polio Vaccine Sales Market Share by Region (2016-2021)
    Table 28. Asia Pacific Polio Vaccine Revenue by Region (2016-2021) & (US$ Million)
    Table 29. Asia Pacific Polio Vaccine Revenue Market Share by Region (2016-2021)
    Table 30. Latin America Polio Vaccine Sales by Country (2016-2021) & (M Doses)
    Table 31. Latin America Polio Vaccine Sales Market Share by Country (2016-2021)
    Table 32. Latin America Polio Vaccine Revenue by Country (2016-2021) & (US$ Million)
    Table 33. Latin America Polio Vaccine Revenue Market Share by Country (2016-2021)
    Table 34. Middle East and Africa Polio Vaccine Sales by Country (2016-2021) & (M Doses)
    Table 35. Middle East and Africa Polio Vaccine Sales Market Share by Country (2016-2021)
    Table 36. Middle East and Africa Polio Vaccine Revenue by Country (2016-2021) & (US$ Million)
    Table 37. Middle East and Africa Polio Vaccine Revenue Market Share by Country (2016-2021)
    Table 38. Global Polio Vaccine Sales (M Doses) by Type (2016-2021)
    Table 39. Global Polio Vaccine Sales Market Share by Type (2016-2021)
    Table 40. Global Polio Vaccine Revenue (Million US$) by Type (2016-2021)
    Table 41. Global Polio Vaccine Revenue Share by Type (2016-2021)
    Table 42. Global Polio Vaccine Price (USD/K Doses) by Type (2016-2021)
    Table 43. Global Polio Vaccine Sales (M Doses) by Application (2016-2021)
    Table 44. Global Polio Vaccine Sales Market Share by Application (2016-2021)
    Table 45. Global Polio Vaccine Revenue (Million US$) by Application (2016-2021)
    Table 46. Global Polio Vaccine Revenue Share by Application (2016-2021)
    Table 47. Global Polio Vaccine Price (USD/K Doses) by Application (2016-2021)
    Table 48. Sanofi Corporation Information
    Table 49. Sanofi Description and Business Overview
    Table 50. Sanofi Polio Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2016-2021)
    Table 51. Sanofi Polio Vaccine Product
    Table 52. Sanofi Recent Developments/Updates
    Table 53. GSK Corporation Information
    Table 54. GSK Description and Business Overview
    Table 55. GSK Polio Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2016-2021)
    Table 56. GSK Polio Vaccine Product
    Table 57. GSK Recent Developments/Updates
    Table 58. Bibcol Corporation Information
    Table 59. Bibcol Description and Business Overview
    Table 60. Bibcol Polio Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2016-2021)
    Table 61. Bibcol Polio Vaccine Product
    Table 62. Bibcol Recent Developments/Updates
    Table 63. Serum Institute Corporation Information
    Table 64. Serum Institute Description and Business Overview
    Table 65. Serum Institute Polio Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2016-2021)
    Table 66. Serum Institute Polio Vaccine Product
    Table 67. Serum Institute Recent Developments/Updates
    Table 68. Tiantan Biological Corporation Information
    Table 69. Tiantan Biological Description and Business Overview
    Table 70. Tiantan Biological Polio Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2016-2021)
    Table 71. Tiantan Biological Polio Vaccine Product
    Table 72. Tiantan Biological Recent Developments/Updates
    Table 73. IMBCA Corporation Information
    Table 74. IMBCA Description and Business Overview
    Table 75. IMBCA Polio Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2016-2021)
    Table 76. IMBCA Polio Vaccine Product
    Table 77. IMBCA Recent Developments/Updates
    Table 78. Panacea Biotec Ltd Corporation Information
    Table 79. Panacea Biotec Ltd Description and Business Overview
    Table 80. Panacea Biotec Ltd Polio Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2016-2021)
    Table 81. Panacea Biotec Ltd Polio Vaccine Product
    Table 82. Panacea Biotec Ltd Recent Developments/Updates
    Table 83. Bio-Med Corporation Information
    Table 84. Bio-Med Description and Business Overview
    Table 85. Bio-Med Polio Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2016-2021)
    Table 86. Bio-Med Polio Vaccine Product
    Table 87. Bio-Med Recent Developments/Updates
    Table 88. Halfkin Bio-Pharmaceuticals Corporation Information
    Table 89. Halfkin Bio-Pharmaceuticals Description and Business Overview
    Table 90. Halfkin Bio-Pharmaceuticals Polio Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2016-2021)
    Table 91. Halfkin Bio-Pharmaceuticals Polio Vaccine Product
    Table 92. Halfkin Bio-Pharmaceuticals Recent Developments/Updates
    Table 93. Production Base and Market Concentration Rate of Raw Material
    Table 94. Key Suppliers of Raw Materials
    Table 95. Polio Vaccine Distributors List
    Table 96. Polio Vaccine Customers List
    Table 97. Polio Vaccine Market Trends
    Table 98. Polio Vaccine Growth Drivers
    Table 99. Polio Vaccine Market Restraints
    Table 100. Global Polio Vaccine Sales Forecast by Type (2022-2027) & (M Doses)
    Table 101. Global Polio Vaccine Sales Market Share Forecast by Type (2022-2027)
    Table 102. Global Polio Vaccine Revenue Forecast by Type (2022-2027) & (US$ Million)
    Table 103. Global Polio Vaccine Revenue Market Share Forecast by Type (2022-2027)
    Table 104. Global Polio Vaccine Sales Forecast by Application (2022-2027) & (M Doses)
    Table 105. Global Polio Vaccine Sales Market Share Forecast by Application (2022-2027)
    Table 106. Global Polio Vaccine Revenue Forecast by Application (2022-2027) & (US$ Million)
    Table 107. Global Polio Vaccine Revenue Market Share Forecast by Application (2022-2027)
    Table 108. Global Polio Vaccine Sales Forecast by Region (2022-2027) & (M Doses)
    Table 109. Global Polio Vaccine Sales Market Share Forecast by Region (2022-2027)
    Table 110. Global Polio Vaccine Revenue Forecast by Region (2022-2027) & (US$ Million)
    Table 111. Global Polio Vaccine Revenue Market Share Forecast by Region (2022-2027)
    Table 112. Research Programs/Design for This Report
    Table 113. Key Data Information from Secondary Sources
    Table 114. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Polio Vaccine
    Figure 2. Global Polio Vaccine Market Share by Type in 2020 & 2027
    Figure 3. Inactivated Polio Vaccine (IPV) Product Picture
    Figure 4. Oral Polio Vaccine (OPV) Product Picture
    Figure 5. Global Polio Vaccine Market Share by Application in 2020 & 2027
    Figure 6. Public
    Figure 7. Private
    Figure 8. Global Polio Vaccine Revenue, (US$ Million), 2016 VS 2021 VS 2027
    Figure 9. Global Polio Vaccine Market Size 2016-2027 (US$ Million)
    Figure 10. Global Polio Vaccine Sales 2016-2027 (M Doses)
    Figure 11. Global Polio Vaccine Market Size Market Share by Region: 2016 VS 20210 VS 2027
    Figure 12. Polio Vaccine Sales Share by Manufacturers in 2020
    Figure 13. Global Polio Vaccine Revenue Share by Manufacturers in 2020
    Figure 14. The Global 5 and 10 Largest Polio Vaccine Players: Market Share by Revenue in 2020
    Figure 15. Polio Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
    Figure 16. Global Polio Vaccine Sales Market Share by Region (2016-2021)
    Figure 17. Global Polio Vaccine Sales Market Share by Region in 2020
    Figure 18. Global Polio Vaccine Revenue Market Share by Region (2016-2021)
    Figure 19. Global Polio Vaccine Revenue Market Share by Region in 2020
    Figure 20. U.S. Polio Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 21. Canada Polio Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 22. Germany Polio Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 23. France Polio Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 24. U.K. Polio Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 25. Italy Polio Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 26. Russia Polio Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 27. China Polio Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 28. Japan Polio Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 29. South Korea Polio Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 30. India Polio Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 31. Australia Polio Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 32. Taiwan Polio Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 33. Indonesia Polio Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 34. Thailand Polio Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 35. Malaysia Polio Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 36. Philippines Polio Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 37. Vietnam Polio Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 38. Mexico Polio Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 39. Brazil Polio Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 40. Argentina Polio Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 41. Turkey Polio Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 42. Saudi Arabia Polio Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 43. U.A.E Polio Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 44. Sales Market Share of Polio Vaccine by Type (2016-2021)
    Figure 45. Sales Market Share of Polio Vaccine by Application (2016-2021)
    Figure 46. Sales Market Share of Polio Vaccine by Application in 2020
    Figure 47. Revenue Share of Polio Vaccine by Application (2016-2021)
    Figure 48. Revenue Share of Polio Vaccine by Application in 2020
    Figure 49. Manufacturing Cost Structure of Polio Vaccine
    Figure 50. Manufacturing Process Analysis of Polio Vaccine
    Figure 51. Polio Vaccine Industrial Chain Analysis
    Figure 52. Channels of Distribution
    Figure 53. Distributors Profiles
    Figure 54. Bottom-up and Top-down Approaches for This Report
    Figure 55. Data Triangulation
    Figure 56. Key Executives Interviewed
Read More
SELECT A FORMAT
Added to Cart

Single User

Electronic (PDF)
$2900
This license allows only one user(purchaser of the report) to access the PDF.

Multi User

Electronic (PDF)
$4350
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)
$5800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
SecuX Technology Inc

RELATED REPORTS

Global Meningococcal Vaccine Market Research Report 2021
Global Meningococcal Vaccine Market Research Report 2021

120 Pages
Type: Report
Code: QYRE-Auto-31I4138
Thu Feb 04 00:00:00 UTC 2021

Add to Cart

Global Latent tuberculosis Testing Market Size Status and Forecast 2021 2027
Global Latent tuberculosis Testing Market Size, Status and Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-33Z4080
Thu Feb 04 00:00:00 UTC 2021

Add to Cart

Global Avian Influenza Vaccines Market Research Report 2021
Global Avian Influenza Vaccines Market Research Report 2021

120 Pages
Type: Report
Code: QYRE-Auto-9K4476
Thu Feb 04 00:00:00 UTC 2021

Add to Cart

Global Polio Vaccine Market Research Report 2021
Global Polio Vaccine Market Research Report 2021

120 Pages
Type: Report
Code: QYRE-Auto-18B4237
Mon Feb 01 00:00:00 UTC 2021

Add to Cart

0 Items
X
No items in the cart.
$0.0